The influence of previous hormone therapy on PSA response in prostate cancer patients (PTS) failing first-line androgen ablation

被引：0
|
作者：
Rassweiler, J [1 ]
机构：
[1] STADTKRANKENHAUS HEILBRONN,HEILBRONN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 32 - 33
  • [32] Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer
    Butcher, Georgiana
    Howard, Harriet
    Sathianathen, Niranjan
    Catto, James W. F.
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2019, 76 (06) : 872 - 873
  • [33] Metastatic breast cancer patients failing first-line, anthracycline-containing chemotherapy: Is further therapy of benefit?
    Campora, E
    Gardin, G
    Gasco, M
    Rosso, R
    Santi, L
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3429 - 3432
  • [34] Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer
    Alcaraz, Antonio
    EUROPEAN UROLOGY, 2020, 77 (02) : 286 - 287
  • [35] Docetaxel, vinorelbine and zoledronic acid as first-line treatment in patients with hormone-refractory prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 95 - 95
  • [36] The influence of androgen deprivation therapy on metabolism in patients with prostate cancer
    Nishiyama, T
    Ishizaki, F
    Anraku, T
    Shimura, H
    Takahashi, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02): : 657 - 660
  • [37] Influence and effectiveness of androgen deprivation therapy for patients with prostate cancer
    Kongseang, C.
    BJU INTERNATIONAL, 2017, 119 : 108 - 108
  • [38] Prostate-specific antigen decline (PSA) as a surrogate for overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) who failed first-line chemotherapy
    Halabi, Susan
    Armstrong, Andrew J.
    Sartor, A. Oliver
    De Bono, Johann Sebastian
    Kaplan, Ellen B.
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancer
    Ceresoli, G. L.
    De Vincenzo, F.
    Sauta, M. G.
    Bonomi, M.
    Zucali, P. A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (04): : 374 - 380
  • [40] Cardiac safety of the lapatinib/letrozole combination as first-line therapy in patients (pts) with metastatic breast cancer (MBC)
    Zembryki, D.
    Gomez, H.
    Koehler, M.
    Koehler, M.
    Johnston, S.
    Pippen, J.
    Florance, A.
    O'Rourke, L.
    Maltzman, J.
    Pivot, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345